New Public Television Special Facilitates National Pain Management Dialogue
The No. 1 reason for physician visits in the U.S. – with annual costs of up to $600 billion – pain often remains neglected and improperly managed
ST. LOUIS--(BUSINESS WIRE)--Everyone experiences pain at some point in their life. Pain is more prevalent than diabetes, cancer and heart disease combined, and yet it is frequently undiagnosed, untreated or undertreated.
“This ITV special underscores our commitment to education, collaboration and safety in this complex arena.”
A new public television special titled “Learning about Pain Management” will begin airing nationally this August on the Public Television Network as part of the Healthy Body, Healthy Mind (HBHM) series. HBHM, a production of the Information Television Network (ITV), is being supported in part by Mallinckrodt Pharmaceuticals without content control. The 30-minute program will take an in-depth look at the physical experience known as “pain,” including how the body senses it and is affected by it, as well as the many pharmacological and non-pharmacological strategies aimed at managing it.
“A collaborative and multidisciplinary approach to pain management is critical, and this new ITV special, which touches upon biofeedback, physical rehabilitation, occupational therapy, medication and counseling, highlights the importance of this strategy,” said Joseph Pergolizzi, MD, Naples Anesthesia and Pain Associates Group in Naples, FL.
The new television program features leading experts in the pain management field from across the U.S.; they address topics ranging from the psychology of pain to rehabilitation and everything in between in order to provide viewers with a wealth of information about chronic and acute pain.
“Mallinckrodt is committed to providing comprehensive, effective treatments for patients who suffer from pain, and is equally committed to combating the misuse and abuse, by some, of pain medicines,” said Dr. Mario Saltarelli, Senior Vice President and Chief Science Officer at Mallinckrodt Pharmaceuticals. “This ITV special underscores our commitment to education, collaboration and safety in this complex arena.”
The program also highlights the real-life experiences of a number of patients and their families to illuminate the impact of pain on people's lives.
Viewers can check their local PBS television listings to learn when the program will air in their area - or go to: http://www.itvisus.com/programs/hbhm.
About Healthy Body, Healthy Mind
Healthy Body, Healthy Mind is a powerful television series that defines and explores today's latest medical progress in health and wellness issues. It is the longest running health and wellness series on public television. The series has aired more than 200 episodes on more than 300 stations nationwide since its debut in 2004.
About Information Television Network (ITV)
As creators/producers of medical documentaries and educational programming since 1992, Information Television Network (ITV) excels at blending key opinion leaders, patients, clinicians, and academia into an informative yet engaging program.
ITV has been the recipient of numerous awards including sixteen (16) Freddie Awards for “Excellence in Health & Medical Media,” three (3) Gracie Awards for “Best National Documentary Series for Women,” and a Regional Emmy for our parenting series Kids Healthworks (produced in association with the American Academy of Pediatrics).
ITV is a content provider for GE Healthcare’s Patient Channel and the Public Television Network.
Mallinckrodt is a global specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. The company’s Specialty Pharmaceuticals segment includes branded and specialty generic drugs and active pharmaceutical ingredients, and the Global Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt has approximately 5,500 employees worldwide and a commercial presence in approximately 65 countries. The company’s fiscal 2013 revenue totaled $2.2 billion. To learn more about Mallinckrodt, visit www.mallinckrodt.com.